Survival rates for women treated for breast cancer run at around 85%, but once the cancer has metastasized chances of recovery plummet to 30%. This is the reason for the creation of Laço hub, at IMM – Portugal’s Institute of Molecular Medicine. Involving scientists, doctors and nurses – and dedicated to patients suffering from metastasized breast cancer – it will be seeking to find answers. As IMM’s director Maria Manuel Mota explains: “We still don’t know why some cancers metastasize and others don’t…” The news comes as Metastatic Breast Cancer Awareness Day is due on October 13.
IMM creates Laço hub “to find solutions for metastatic breast cancer”
